Literature DB >> 19156356

Moderate clinical improvement with maintenance ECT in a 17-year-old boy with intractable catatonic schizophrenia.

Angèle Consoli1, Valérie Boulicot, Françoise Cornic, Philippe Fossati, Martine Barbeau, David Cohen.   

Abstract

The use of electro-convulsive therapy (ECT) in adolescents is controversial, and few studies have been conducted to assess its efficacy and safety in this population. We report the case of a 19-year-old boy who received two series of ECT, one at 15 and another at 16, for intractable catatonic schizophrenia. Since the age of 17, he has required treatment combining clozapine and maintenance ECT. The course showed a sustained moderate improvement. The treatment permitted the patient to regain some autonomy with moderate adverse effects. ECT remains an uncommon treatment in adolescents, and the current case supports the view that it should not be banned in young people.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19156356     DOI: 10.1007/s00787-008-0724-6

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  33 in total

1.  Electroconvulsive therapy in adolescents: similarities to and differences from adults.

Authors:  Y Bloch; Y Levcovitch; A M Bloch; S Mendlovic; G Ratzoni
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2001-11       Impact factor: 8.829

2.  Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled cross-over study.

Authors:  G S Ungvari; H F Chiu; L Y Chow; B S Lau; W K Tang
Journal:  Psychopharmacology (Berl)       Date:  1999-03       Impact factor: 4.530

3.  Use of electroconvulsive therapy in adolescents.

Authors:  D Cohen; M L Paillère-Martinot; M Basquin
Journal:  Convuls Ther       Date:  1997-03

4.  An epidemiological study of the use of ECT in adolescents.

Authors:  G Walter; J M Rey
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-06       Impact factor: 8.829

5.  ECT and young minds.

Authors:  T Baker
Journal:  Lancet       Date:  1995-01-07       Impact factor: 79.321

6.  Effects of electroconvulsive therapy in adolescents with severe endogenous depression resistant to pharmacotherapy.

Authors:  M Strober; U Rao; M DeAntonio; E Liston; M State; L Amaya-Jackson; S Latz
Journal:  Biol Psychiatry       Date:  1998-03-01       Impact factor: 13.382

Review 7.  Towards a valid nosography and psychopathology of catatonia in children and adolescents.

Authors:  David Cohen
Journal:  Int Rev Neurobiol       Date:  2006       Impact factor: 3.230

8.  Clinical relevance of chronic catatonic schizophrenia in children and adolescents: evidence from a prospective naturalistic study.

Authors:  David Cohen; Jean-Dominique Nicolas; Martine F Flament; Didier Périsse; Pierre-François Dubos; Olivier Bonnot; Mario Speranza; Catherine Graindorge; Sylvie Tordjman; Philippe Mazet
Journal:  Schizophr Res       Date:  2005-07-15       Impact factor: 4.939

9.  Electroconvulsive Therapy in Adolescents.

Authors:  Terry D. Schneekloth; Teresa A. Rummans; Kathleen M. Logan
Journal:  Convuls Ther       Date:  1993

Review 10.  Catatonia in autism: implications across the life span.

Authors:  Angelina Kakooza-Mwesige; Lee E Wachtel; Dirk M Dhossche
Journal:  Eur Child Adolesc Psychiatry       Date:  2008-04-21       Impact factor: 4.785

View more
  3 in total

1.  Treatment use in a prospective naturalistic cohort of children and adolescents with catatonia.

Authors:  Marie Raffin; Laetitia Zugaj-Bensaou; Nicolas Bodeau; Vanessa Milhiet; Claudine Laurent; David Cohen; Angèle Consoli
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-08-27       Impact factor: 4.785

2.  Electroconvulsive therapy resolves cortical inhibition and manneristic omissions in a chronic catatonic patient.

Authors:  T Dresler; A S Giani; C Reinsberger; P Scheuerpflug; G Stöber; A J Fallgatter
Journal:  J Neural Transm (Vienna)       Date:  2010-09-01       Impact factor: 3.575

Review 3.  Current approaches to treatments for schizophrenia spectrum disorders, part I: an overview and medical treatments.

Authors:  Wai Tong Chien; Annie Lk Yip
Journal:  Neuropsychiatr Dis Treat       Date:  2013-09-11       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.